Revolution Medicines (RVMD) Share-based Compensation (2019 - 2026)
Revolution Medicines' Share-based Compensation came in at $67 million for Q2 2026, up 132.4% from $28.83 million a year earlier but down 23.3% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Revolution Medicines reported Share-based Compensation of $218.77 million, up 125.2% year-over-year; for FY2025, it was $118.39 million, up 49.5% from FY2024.
- Share-based Compensation has increased in each of the last seven years, with a five-year compound annual growth rate of 67.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $79.2 million in FY2024 (+28.2%), $61.77 million in FY2023 (+98.0%), $31.2 million in FY2022 (+50.5%) and $20.72 million in FY2021 (+133.2%).
- The five-year range for quarterly Share-based Compensation is $5.83 million (Q3 2021) to $87.3 million (Q1 2026).
- Year-over-year, Share-based Compensation has increased for six consecutive quarters, with growth averaging 77.4% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2026 (growth of 248.0%), and the weakest in Q4 2024 (a decline of 11.8%).
- Business Quant data shows RVMD's Share-based Compensation at $87.3 million (Q1 2026), $33.7 million (Q4 2025) and $30.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 67.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.00 Mn |
| Mar 31, 2026 | 87.30 Mn |
| Dec 31, 2025 | 33.70 Mn |
| Sep 30, 2025 | 30.78 Mn |
| Jun 30, 2025 | 28.83 Mn |
| Mar 31, 2025 | 25.08 Mn |
| Dec 31, 2024 | 22.44 Mn |
| Sep 30, 2024 | 20.78 Mn |
| Jun 30, 2024 | 19.78 Mn |
| Mar 31, 2024 | 16.21 Mn |
| Dec 31, 2023 | 25.43 Mn |
| Sep 30, 2023 | 13.67 Mn |
| Jun 30, 2023 | 12.98 Mn |
| Mar 31, 2023 | 9.70 Mn |
| Dec 31, 2022 | 8.32 Mn |
| Sep 30, 2022 | 8.14 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 6.20 Mn |
| Sep 30, 2021 | 5.83 Mn |
API Access
Revolution Medicines Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();